Outcome Evaluation of a Subcutaneous Immunoglobulin Clinical Management Program

OBJECTIVE: The aim of this study is to compare clinical and cost outcomes of patients undergoing subcutaneous immunoglobulin (SCIG) therapy who were managed by a clinical management program to the matched controls in the United States. METHODS: This was a retrospective cohort study using administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Julia, Ayer, Gretchen, Kirkham, Heather S., Chen, Chi-Chang, Wade, Rolin L., Karkare, Swapna U., Robson, Chester H., Orange, Jordan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636416/
https://www.ncbi.nlm.nih.gov/pubmed/31367639
http://dx.doi.org/10.4103/jrpp.JRPP_18_36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636416/
https://www.ncbi.nlm.nih.gov/pubmed/31367639
http://dx.doi.org/10.4103/jrpp.JRPP_18_36

Ejemplares similares